Christian Pellegrino

17PUBLICATIONS
58CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 11, 2026
A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells.

|May 07, 2026
CAR T-cells targeting CD117 effectively eliminate mast cells in preclinical models of advanced systemic mastocytosis.

|Mar 30, 2026
Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia.

Mara Hofstetter, Laura Volta, Christian Koch

|Mar 17, 2026
A bispecific anti-fluorescein x anti-CD3 T-cell engager in combination with fluoresceinated adaptors enables lysis of AML cells.

Laura G Volta, Celeste Gobbi, Christian Koch

|Oct 24, 2025
Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance.

Marianna Ponzo, Lorenzo Drufuca, Chiara Buracchi

|Sep 30, 2025
Immunocompetent Mouse Models of Cancer Reveal the Superiority of Cellular Targets over Stromal Targets for the Development of Anticancer Bispecific Antibodies.

Stefanie K Pfister, Frauke Seehusen, Francesco Prisco

Pageof 3

Frequent Collaborators

12 joint publications

Markus G Manz

10 joint publications

Dario Neri

5 joint publications

Christian Koch

5 joint publications

Chiara F Magnani